Phase 3 Study of Desogestrel and Ethinyl Estradiol Combined Oral Contraceptive for Pregnancy Prevention

2014 ◽  
Vol 123 ◽  
pp. 107S-108S
Author(s):  
Robin Kroll ◽  
Brandon Howard ◽  
Jennifer Hsieh ◽  
Nancy Ricciotti
Keyword(s):  
Oral Contraceptive ◽  
Ethinyl Estradiol ◽  
Pregnancy Prevention ◽  
Phase 3 ◽  
Combined Oral Contraceptive

scholarly journals Safety and Efficacy of Levonorgestrel 0.10 mg and Ethinyl Estradiol 0.02 mg plus Ethinyl Estradiol 0.01 mg in an Extended-Cycle Oral Contraceptive Regimen

2010 ◽  
Vol 2 ◽  
pp. CMT.S4661
Author(s):  
Radhika Rible ◽  
Ram Parvataneni ◽  
Angela Chen
Keyword(s):  
Oral Contraceptive ◽  
Ethinyl Estradiol ◽  
Hormonal Contraception ◽  
Pivotal Trial ◽  
Combined Oral Contraceptive ◽  
Free Interval ◽  
Effective Option ◽  
Effective Contraception ◽  
Combined Hormonal Contraception ◽  
Extended Cycle

Extended-cycle combined hormonal contraception has become a common practice among women seeking effective contraception and menstrual regulation. Extended cycle regimens have the benefit of decreasing scheduled bleeding as compared to traditional combined oral contraceptive (COC) regimens containing 21 days of hormones followed by a 7-day hormone-free interval (HFI) by reducing the frequency of the HFI. The newest FDA approved product in this family of contraceptive regimens is a 91-day COC regimen containing 0.02 mg ethinyl estradiol (EE) and 0.1 mg levonorgestrel (LNG) for 84 days followed by a 7-day interval with 0.01 mg EE. This regimen has been evaluated in one pivotal trial and demonstrated to have efficacy and a side effect profile similar to the other currently available FDA approved 91-day extended-cycle regimens. This is the first 91-day regimen formulated with 0.02 mg EE and offers women an effective option for contraception and menstrual cycle control.

Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 μg of ethinyl estradiol on the human endometrium

2001 ◽  
Vol 76 (1) ◽  
pp. 102-107 ◽  
Author(s):  
Frank Lüdicke ◽  
Elisabeth Johannisson ◽  
Frans M Helmerhorst ◽  
Aldo Campana ◽  
Jean-Michel Foidart ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Ethinyl Estradiol ◽  
Human Endometrium ◽  
Combined Oral Contraceptive

scholarly journals Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive

Contraception ◽  
2014 ◽  
Vol 89 (4) ◽  
pp. 299-306 ◽  
Author(s):  
David J. Portman ◽  
Andrew M. Kaunitz ◽  
Brandon Howard ◽  
Herman Weiss ◽  
Jennifer Hsieh ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Ethinyl Estradiol ◽  
Efficacy And Safety ◽  
Combined Oral Contraceptive

Safety and efficacy of a combined oral contraceptive: Gestodene 75 μg plus ethinyl estradiol 30 μg in Mexican women

1994 ◽  
Vol 10 (1) ◽  
pp. 19-26 ◽  
Author(s):  
J. Garza-Flores ◽  
V. Valles de Bourges ◽  
M. Martínez ◽  
L. Vázquez-Estrada ◽  
S. Bassol ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Ethinyl Estradiol ◽  
Mexican Women ◽  
Safety And Efficacy ◽  
Combined Oral Contraceptive
Sign in / Sign up

Export Citation Format

Share Document